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Supplemental Guidance for Planning and Implementing the National 
Smallpox Vaccination Program (NSVP) 
 
A. Background 
 
This document provides additional supplemental guidance for recipients of federal funding 
through the Public Health Preparedness and Response for Bioterrorism (PHPRB) 
Cooperative Agreement (Announcement Number 99051) for the purpose of supporting 
smallpox preparedness and response.  This supplemental guidance (amending the Guidance 
for Post-event Smallpox Planning issued by CDC on October 28, 2002) provides additional 
specificity to support the vaccination of healthcare and public health smallpox response 
teams.    
 
B. Goal of this Activity 
 
To increase the nation’s smallpox preparedness capacity by: (1) offering vaccination safely to 
volunteer public health teams (including vaccinators) to conduct investigations and outbreak 
control for the initial cases of a smallpox event; and (2) offering vaccinations safely to key 
volunteer healthcare workers who would treat and manage the initial smallpox cases and 
suspects.  
    
C. Funding 
 
The activities necessary to plan and implement this initiative involve the critical and 
enhanced capacities in the 7 Focus Areas for which funding was provided through the 
supplemental PHPRB Cooperative Agreement funds in February 2002. Recipients are 
encouraged to utilize these funds to plan and implement this initiative and should redirect 
funds, as necessary, in accordance with the PHS Grants Policy Statement and guidance 
documents previously issued by CDC for this cooperative agreement.  
 
D. Timeline 
 
Immunization operations should be completed within 30 days of the program’s announced 
start date.  
 
E. Plan Format and Content 
 
PHPRB grantees are requested to develop a plan that addresses the how they will satisfy the 
goal of this activity.  The implementation plans must include, at minimum, the plan 
requirements listed below:  
 
1.  Organization and Management 
PHPRB grantees will be responsible for implementing and managing the smallpox 
immunization program. Each grantee must appoint a coordinator for the smallpox 
immunization program. Plans should include a description of the program operation 
and management. Advice on program implementation should be sought from the 
health department Bioterrorism Advisory Committee and appropriate healthcare 
partners. 
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Plan Requirements: 
• Identification of management personnel by position title, program function, 
contact information and name (if possible.) 
• A timeline for program implementation 
• An organizational chart showing the structure and management of the 
smallpox immunization program. 
 
2.  Identification of public health smallpox response teams   
Each grantee should have at least one public health smallpox response team. Each 
team should include a medical expert as team leader, public health advisors, medical 
epidemiologists, disease investigators, diagnostic laboratory scientists, laboratory 
response network (laboratorians assigned to perform vaccinia and othropox 
diagnostics within LRN laboratory network) nurses, vaccinators, and other necessary 
personnel as determined by state and local officials. ACIP suggests that where 
possible previously vaccinated public health personnel be made part of the response 
teams. (Annex 1) 
 
Plan Requirements: 
• The number of teams needed.  
• The proposed composition of teams by position, title, role and agency 
affiliation 
• A timeline for selection and vaccination of individual team members.  
 
3.  Identification of Healthcare Smallpox  Response Teams  
Grantees will need to collaborate with appropriate local health agencies, medical and 
hospital organizations and individual hospitals to develop the criteria for and numbers 
of hospitals to be involved and in identifying individual health care workers to be 
offered vaccine.   
 
Plan Requirements: 
• The estimated number of hospitals and healthcare response teams expected to 
participate 
• A policy defining hospital responsibilities, including pre-program education, 
screening, adverse event evaluation, and treatment, daily vaccination site 
management, and evaluation of vaccination takes. 
• The estimated number and occupational types of healthcare personnel 
expected to be vaccinated  
• A timeline for selection of hospitals and individual health care workers and 
the vaccination of healthcare response teams  
 
4.  Selection of Clinic Sites and Vaccination Teams  
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The NSVP envisions limiting the number of vaccination clinic sites in each grantee 
area to a few, fixed, geographically distributed sites. In addition, grantees may choose 
to use clinic teams or sub-teams that operate from a clinic base to perform 
vaccinations as required by population and hospital distributions. The rationale for 
this includes: the packaging of smallpox vaccine in 100 dose vials, the currently 
limited supply of smallpox vaccine, the need for careful vaccine handling that 
minimizes wastage and ensures security, and the level of supervision and expertise 
required to maintain the highest quality of patient screening and vaccination practices, 
thereby maximizing the safe use of the vaccine.  
 
Each grantee will be responsible for determining the number, staffing needs and 
location of clinic sites for smallpox vaccination operations.  
  
Plan Requirements: 
• The number and tentative location of clinic sites  
• A timeline for selection of clinic sites and clinic vaccination teams 
• A plan for training members of the clinic teams and for providing supervision 
management and evaluation of the clinic and clinic team members  
• The intended days and hours of clinic operation 
• The estimated total number of clinic personnel needed 
 
5.  Scheduling  
State and local health departments, selected hospitals, public response health teams, 
and the vaccination clinics will collaborate on the clinic site and scheduling for 
hospital medical team and public health team volunteers for screening and 
vaccination. Care should be taken to schedule vaccinations to minimize vaccine 
wastage and work disruption among vaccinees of participating hospitals and public 
health teams.  
 
Plan Requirements: 
• An estimate of the total number of persons who will be vaccinated each week 
• A strategy for scheduling vaccinations of hospital and public health smallpox 
response teams 
 
6.  Vaccine Logistics and Security 
CDC is prepared to ship vaccine to 62 grantees and will be responsible for security 
from the repository designated by each grantee.  CDC will provide smallpox handling 
instructions, cold chain management guidance, handling instructions, and all 
appropriate documentation.  CDC will deliver Dryvax smallpox vaccine, packaged 
and shipped in increments as small as one vial (100 doses).  CDC will validate all 
delivery information prior to shipment and release vaccine after validation of 
temperature monitoring information. 
Licensed vaccine is packaged as a ‘kit’ made up of 1 vial smallpox vaccine, 1 vial of 
diluent for 100 doses, 100 bifurcated needles, one transfer syringe and needle, 
package insert and lot number stickers. This vaccine, reconstituted with the diluent, 
can be used over several clinic sessions, if handled correctly. Storage requirements 
are described in detail in the Annex 2. 
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Plan requirements: 
• Provide primary and alternate point of contact, alternate phone numbers, fax 
numbers, and a designated ship-to address.  
• Number of required doses 
• A strategy for managing and safeguarding the vaccine and related supplies  
 
For questions on logistics and security, please call the NPS program # 404-639-0459. 
Please reference smallpox vaccine when talking to the operator. 
 
7.  Clinic Operations and Management 
 
Every grantee will be responsible for establishing an integrated clinic strategy and 
flow that will maximize the efficiency of the fixed clinics and/or sub teams operating 
outside of fixed clinics and the utilization of the vaccine. Clinic staff must be 
responsible for essential clinic functions including establishing patient flow, record 
keeping, educating and screening potential vaccinees; clinic security; ensuring 
adequate educational materials, forms, and other supplies, stocking of medical 
supplies, worker safety, obtaining consent, vaccine handling, vaccination, acute 
medical reaction management, data collection/entry into the information system, 
vaccine accountability, post vaccination wound management, waste disposal, advice 
on adverse events and reporting, completing the vaccinee’s vaccination card, and 
evaluating for vaccine take for personnel referred back to the clinic for take 
documentation (e.g. those not affiliated with specific hospital/clinic that will evaluate 
their own staff takes). Annex 3 provides detailed information on clinic operations, 
including forms, suggested supplies, and check lists.  
 
Plan Requirements: 
• Description of the process for ensuring adequate screening of potential 
vaccinees 
• Plans to ensure clinics have adequate supplies and equipment and educational 
and screening materials.  
• A timeline for implementing clinic operations  
 
8.  Vaccine Safety Monitoring, Reporting, Treatment and Patient Referral  
Grantee’s plans must describe how they will interface with the Smallpox 
Immunization Safety System (SISS) provided in Annex 4. General information on 
smallpox, smallpox vaccine and vaccination, contraindications and adverse events is 
available through the CDC Smallpox web-site www.bt.cdc.gov/agent/smallpox. 
 
Plan Requirements 
 
• The name and position of the individual(s) responsible for coordinating 
vaccine safety monitoring, reporting, treatment and patient referral  
• A plan that describes how the grantee will provide for vaccine safety 
monitoring, reporting, treatment and patient referral (see Annex 4)  
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9.  Training and Education 
State and local health departments, hospitals, professional organizations, and others 
will require general education and training on the components of the smallpox 
vaccination plan. A variety of methods, venues, and materials can be used. CDC will 
provide and deliver training and educational materials in a variety of methods 
including live satellite broadcasts, webcasts, audiocasts, videotapes, CD ROMS, web-
based and printed materials.  A list of training materials under development by the 
CDC is provided in CDC’s Smallpox Vaccine Program Training and Education Plan 
(Annex 5). 
 
Plan requirements: 
• A plan for conducting training of vaccination clinic staff on critical 
components of the plan including, venues for training, specific personnel to be 
trained, and a timeline for implementation 
 
10.  Data Management 
Detailed information will be needed on an ongoing, real-time basis to inform policy 
makers, health officials, clinic managers, and the public about the status of a smallpox 
vaccination program. Data derived from the clinics must be analyzed frequently to 
enable managers at all levels to identify and resolve problems, evaluate progress 
toward meeting objectives and redirect the activities, as necessary.  
 
Grantees will choose from one of the three following options for providing smallpox 
vaccination information to the CDC: (1) use the Pre-Event Vaccination System (PVS) 
described in the Annex 8 with named data; (2) use the (PVS) application without 
named data; or 3) perform data exchange with the CDC from a certified, alternative 
state system. Grantees are strongly encouraged to pursue option #1 or option #2 until 
certification of data exchange from an alternative system is established. The use of 
named data is solely for the support of state functionality of the (PVS) application. 
The CDC will not use named data. 
 
All grantee systems will be expected to meet the functional systems requirements 
identified in the Annex 6, which provides the minimum functional requirements that 
a vaccination record system must provide related to the support of a smallpox 
vaccination program.  
 
Systems developed or purchased by grantees (option #3 above) must also meet the 
data exchange requirements outlined in Annex 7. Detailed formats of required and 
optional data that will be reported to the CDC to support monitoring efforts of the 
vaccination program are also provided.  
 
Plan requirements: 
• The name, position, and contact numbers of the individuals designated to 
oversee, coordinate and collaborate with state, local, clinic and CDC data 
management and information experts to facilitate full knowledge, 
understanding, acceptance and support of the system, its implementation and 
maintenance, and its evaluation. 
                                                                 6 of 9 
• Description of how the State and clinics will support and integrate with 
VAERS and CDC’s web-based information system (PVS) in identified clinic 
settings 
 
11. Communications  
Medical and public health professionals and the public must realize the purpose of 
this activity and that federal, state, and local health officials, hospitals and provider 
professional organizations are collaboratively responding to strengthen the nation’s 
ability to effectively manage a smallpox emergency if one were to occur.  Given the 
short timetable for program implementation, grantees are encouraged to use existing 
CDC communications materials but should develop grantee-specific communication 
when time allows. Additional reference information concerning helpful URLs and 
key facts can be found in Annex 9 and Annex 10.  
 
Plan Requirements: 
• Identify a point of contact responsible for communications associated with 
this activity 
• Address critical communication issues 
 
F. Reporting Requirements 
 
Grantees will be required to submit semi-weekly status reports on each Monday and 
Thursday throughout the vaccination program. These reports should be submitted to 
National Immunization Program, Data Management Division.  A reporting form with 
required data elements is provided in Annex 11.  
 
G.  Approval 
 
Plans will be evaluated against the requirements stated in the Plan Format and Content 
section. Project officers will contact and work with grantees as necessary to obtain 
critical information not included in the plan as submitted. Upon the approval of CDC, 
(and a federal decision allowing the use of vaccine) vaccine will be released to the 
grantees in accordance with protocols of the National Pharmaceutical Stockpile at CDC.  
 
H.  Plan Submission and Deadline 
  
 Please submit supplemental plans via email as Microsoft Word attachments by COB on 
December 9, 2002 to: 
  
 Glen Koops  
 Director, State and Local Preparedness Program 
 Officer of Terrorism Preparedness and Response 
 Centers for Disease Control and Prevention  
 gak3@cdc.gov 
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I.  Where to Obtain Additional Information 
 
For additional programmatic information concerning planning and implementation of the 
NSVP, please contact: 
 
Tom Hicks 
Program Operations Branch  
Immunization Services Division 
National Immunization Program  
Centers for Disease Control and Prevention 
404-639-8215 
twh1@cdc.gov 
  
For information concerning the use of funds provided through the PHPRB Cooperative 
Agreement for this project, please contact your designated BT project officer or PGO 
grants specialist.  
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